Navigation Links
Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing
Date:3/3/2010

IRVINE, Calif., March 3 /PRNewswire/ -- Avrio Biopharmaceuticals, LLC, a premier contract development and manufacturing organization, announced the addition of Yvonne Verburgt as Vice President of Business Development and Marketing. Yvonne brings over 28 years of pharmaceutical industry experience to the company and to the clients it serves.  

"We are very excited to bring Yvonne on board," said Assad J. Kazeminy, President and Founder of Avrio Biopharmaceuticals. "Yvonne brings years of experience with a remarkable track record to our executive team. She is an innovative and seasoned scientific sales leader and I look forward to the great contributions she will bring to the company and our clients."

Yvonne's most recent venture as the head of Business Development at Pharmatek Laboratories, Inc. involved successfully leading the sales team to help expand business of pharmaceutical chemistry development services. Her previous work experience includes serving as the Director of North American Sales for Patheon, Inc., and holding similar sales and management roles for companies including Oread, Inc., Becton Dickinson, Behring Diagnostics, Abbott Laboratories, and Johnson & Johnson. 

"Yvonne's extensive history in science and sales makes her an ideal addition to our executive team," said Aryo A. Nikopour, Vice President of Scientific and Technical Services. "She brings an impressive depth of knowledge and leadership skills and will be instrumental in building our customer-centric business."

You can learn more about Avrio and the executive team at the upcoming 2010 PDA Annual Meeting, booth 714.

About Avrio Biopharmaceuticals, LLC

Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, specializing in preformulation/formulation, analytical development, process validation, scale-up studies, packaging and labeling, stability storage and complete analytical CMC testing. Learn more at www.avriobiopharma.com or call 866-98-AVRIO (866-982-8746).

SOURCE Avrio Biopharmaceuticals, LLC

Back to top

RELATED LINKS
http://www.avriobiopharma.com
http://www.irvinepharma.com

'/>"/>

SOURCE Avrio Biopharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lumetra PSO Joins Forces With iSOFT Solutions
2. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
3. Top Bristol-Myers Squibb Executive Joins Patton Boggs
4. Government Relations CEO Joins MedeFile Advisory Board
5. Eamonn Hobbs Joins the Board of Directors at Cappella
6. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
7. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
8. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
9. New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nations First In Vitro Fertilization Insurance Program
10. CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
11. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)...  Bayer has awarded grants totaling more than $2 million ... prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and ... and Uniformed Services University of the Health Sciences in ... recipients were announced last night during a reception at the ... Berlin, Germany . ...
(Date:7/11/2017)... LINCOLNSHIRE, Ill. , July 11, 2017 /PRNewswire/ ... hematology and urinalysis diagnostic testing equipment as well ... latest innovation: a way to make quality assurance ... control processes. "Sysmex is well known for the ... SM Quality Monitor elevates quality assurance processes ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... development of oral drug delivery systems, announced today that ... to schedule an End-of-Phase II meeting with Oramed for ... insulin capsule ORMD-0801 in the treatment of type 2 ... endpoints by indicating a statistically significant lowering of glucose ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... July 20, 2017 , ... ... IT operations analytics and application performance monitoring (APM) solutions, has expanded its ... services providers. , According to Peter Ohrenberger, sales director at Nastel, “We’ve ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... platform, in which their iMedSecure™ comes included with each system installation. RMT’s ... images to remote participants for real-time collaboration and immediate decision-making requirements. While ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar ... non-invasive devices and systems for monitoring cardiopulmonary diseases, announced today that it has ... to complete regulatory submissions and fund final engineering and initial production of the ...
(Date:7/20/2017)... , ... July 20, 2017 , ... The Dermatology Clinic ... Dr. Dunbar received his BS in Biology from LSU, graduating summa cum laude. He ... Class President. After his residency in St. Louis, Dr. Dunbar moved to New York ...
(Date:7/20/2017)... CA (PRWEB) , ... July 20, 2017 , ... ... A Guide to the Business Architecture Body of Knowledge (BIZBOK® Guide )v 6.0 ... members who contributed to this effort through Guild collaborative teams. , Non-members may ...
Breaking Medicine News(10 mins):